Rongbing Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rongbing Xie has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Daniel I. Chu
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
3 shared publications - Isabel C. Dos Santos Marques
Division of Gastrointestinal Surgery, University of Alabama at Birmingham, Birmingham, AL, USA
3 shared publications - Aniket Malhotra
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham
2 shared publications - Connie C. Shao
University of Alabama at Birmingham Heersink School of Medicine, AL, USA
2 shared publications - Gray McPherson
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL (AM, GEM, LL)
2 shared publications - Gregory D. Kennedy
University of Alabama at Birmingham
2 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e109601
A Comprehensive Intervention to Enhance Treatment Engagement and Retention Following Nonfatal Opioid Overdose: Protocol for a Single-Arm Prospective Feasibility Study
Background: Substance use treatment engagement and retention after hospital discharge remain low among patients with nonfatal opioid overdose. It is critical to develop interventions targeting this population due to the persistent opioid overdose crisis. Objective: We conducted a single-arm prospective study, the first phase of a 2-phase study (R61/R33, funded by the National Institute on Drug Abuse; DA062351). The objective of the R61 phase was to evaluate the feasibility and acceptability of a 12-week bundled telehealth-enabled intervention aimed at improving treatment engagement and retention among patients with opioid use disorder and a recent nonfatal opioid overdose after hospital discharge. Methods: The R61 phase was a single-arm study with no control group. The 12-week comprehensive intervention comprised 4 components, including buprenorphine treatment, telehealth physician visits (weeks 1, 3, 5, 9, and 12 and as needed), telehealth peer service (daily during week 1, every other day during week 2, weekly during weeks 3-12, and as needed), and facilitated linkage to community resources and ongoing treatment. Adults aged 19 years or older with a diagnosis of opioid use disorder and a nonfatal opioid overdose within the previous 12 months were recruited before they were discharged from the University of Alabama at Birmingham Hospital. After enrollment, buprenorphine treatment was initiated or continued, and peer support specialists began engaging and coaching patients. Participants completed validated surveys at baseline and 1 and 3 months. Feasibility will be measured using enrollment and retention rates (benchmark of ≥70% at 3 months). Acceptability will be measured using patient satisfaction and credibility and expectancy scores. Mental health, craving, repeat overdose, and emergency department revisits and readmissions are secondary outcomes. Outcomes will be summarized descriptively. Results: The R61 study was funded by the National Institute on Drug Abuse from October 1, 2024, to August 30, 2026. All 30 anticipated participants were enrolled, and 24 completed the intervention. The last participant completed the intervention in April 2026. Data analysis is currently ongoing, and results from the current study are expected to be published in January 2027. Funding for the subsequent R33 phase was awarded in September 2026. Conclusions: This study evaluated the feasibility and acceptability of a bundled telehealth-enabled intervention for patients at high risk of repeat overdose and death, a patient population with low treatment uptake and retention after hospital discharge. The findings will inform the upcoming R33 phase, a randomized controlled trial aiming to demonstrate effectiveness in an estimated sample of 160 patients. International Registered Report Identifier (IRRID): DERR1-10.2196/109601
- 17 November 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e109601
Open AccessA Comprehensive Intervention to Enhance Treatment Engagement and Retention Following Nonfatal Opioid Overdose: Protocol for a Single-Arm Prospective Feasibility Study
Background: Substance use treatment engagement and retention after hospital discharge remain low among patients with nonfatal opioid overdose. It is critical to develop interventions targeting this population due to the persistent opioid overdose crisis. Objective: We conducted a single-arm prospective study, the first phase of a 2-phase study (R61/R33, funded by the National Institute on Drug Abuse; DA062351). The objective of the R61 phase was to evaluate the feasibility and acceptability of a 12-week bundled telehealth-enabled intervention aimed at improving treatment engagement and retention among patients with opioid use disorder and a recent nonfatal opioid overdose after hospital discharge. Methods: The R61 phase was a single-arm study with no control group. The 12-week comprehensive intervention comprised 4 components, including buprenorphine treatment, telehealth physician visits (weeks 1, 3, 5, 9, and 12 and as needed), telehealth peer service (daily during week 1, every other day during week 2, weekly during weeks 3-12, and as needed), and facilitated linkage to community resources and ongoing treatment. Adults aged 19 years or older with a diagnosis of opioid use disorder and a nonfatal opioid overdose within the previous 12 months were recruited before they were discharged from the University of Alabama at Birmingham Hospital. After enrollment, buprenorphine treatment was initiated or continued, and peer support specialists began engaging and coaching patients. Participants completed validated surveys at baseline and 1 and 3 months. Feasibility will be measured using enrollment and retention rates (benchmark of ≥70% at 3 months). Acceptability will be measured using patient satisfaction and credibility and expectancy scores. Mental health, craving, repeat overdose, and emergency department revisits and readmissions are secondary outcomes. Outcomes will be summarized descriptively. Results: The R61 study was funded by the National Institute on Drug Abuse from October 1, 2024, to August 30, 2026. All 30 anticipated participants were enrolled, and 24 completed the intervention. The last participant completed the intervention in April 2026. Data analysis is currently ongoing, and results from the current study are expected to be published in January 2027. Funding for the subsequent R33 phase was awarded in September 2026. Conclusions: This study evaluated the feasibility and acceptability of a bundled telehealth-enabled intervention for patients at high risk of repeat overdose and death, a patient population with low treatment uptake and retention after hospital discharge. The findings will inform the upcoming R33 phase, a randomized controlled trial aiming to demonstrate effectiveness in an estimated sample of 160 patients. International Registered Report Identifier (IRRID): DERR1-10.2196/109601
- Open Access
- 14 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
A Comprehensive Intervention to Enhance Treatment Engagement and Retention Following Nonfatal Opioid Overdose: Protocol for a Single-Arm Prospective Feasibility Study (Preprint)
BACKGROUND Substance use treatment engagement and retention after hospital discharge remain low among patients with nonfatal opioid overdose. It is critical to develop interventions targeting this population due to the persistent opioid overdose crisis. OBJECTIVE We conducted a single-arm prospective study, the first phase of a 2-phase study (R61/R33, funded by the National Institute on Drug Abuse; DA062351). The objective of the R61 phase was to evaluate the feasibility and acceptability of a 12-week bundled telehealth-enabled intervention aimed at improving treatment engagement and retention among patients with opioid use disorder and a recent nonfatal opioid overdose after hospital discharge. METHODS The R61 phase was a single-arm study with no control group. The 12-week comprehensive intervention comprised 4 components, including buprenorphine treatment, telehealth physician visits (weeks 1, 3, 5, 9, and 12 and as needed), telehealth peer service (daily during week 1, every other day during week 2, weekly during weeks 3-12, and as needed), and facilitated linkage to community resources and ongoing treatment. Adults aged 19 years or older with a diagnosis of opioid use disorder and a nonfatal opioid overdose within the previous 12 months were recruited before they were discharged from the University of Alabama at Birmingham Hospital. After enrollment, buprenorphine treatment was initiated or continued, and peer support specialists began engaging and coaching patients. Participants completed validated surveys at baseline and 1 and 3 months. Feasibility will be measured using enrollment and retention rates (benchmark of ≥70% at 3 months). Acceptability will be measured using patient satisfaction and credibility and expectancy scores. Mental health, craving, repeat overdose, and emergency department revisits and readmissions are secondary outcomes. Outcomes will be summarized descriptively. RESULTS The R61 study was funded by the National Institute on Drug Abuse from October 1, 2024, to August 30, 2026. All 30 anticipated participants were enrolled, and 24 completed the intervention. The last participant completed the intervention in April 2026. Data analysis is currently ongoing, and results from the current study are expected to be published in January 2027. Funding for the subsequent R33 phase was awarded in September 2026. CONCLUSIONS This study evaluated the feasibility and acceptability of a bundled telehealth-enabled intervention for patients at high risk of repeat overdose and death, a patient population with low treatment uptake and retention after hospital discharge. The findings will inform the upcoming R33 phase, a randomized controlled trial aiming to demonstrate effectiveness in an estimated sample of 160 patients. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/109601
- 14 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Comprehensive Intervention to Enhance Treatment Engagement and Retention Following Nonfatal Opioid Overdose: Protocol for a Single-Arm Prospective Feasibility Study (Preprint)
BACKGROUND Substance use treatment engagement and retention after hospital discharge remain low among patients with nonfatal opioid overdose. It is critical to develop interventions targeting this population due to the persistent opioid overdose crisis. OBJECTIVE We conducted a single-arm prospective study, the first phase of a 2-phase study (R61/R33, funded by the National Institute on Drug Abuse; DA062351). The objective of the R61 phase was to evaluate the feasibility and acceptability of a 12-week bundled telehealth-enabled intervention aimed at improving treatment engagement and retention among patients with opioid use disorder and a recent nonfatal opioid overdose after hospital discharge. METHODS The R61 phase was a single-arm study with no control group. The 12-week comprehensive intervention comprised 4 components, including buprenorphine treatment, telehealth physician visits (weeks 1, 3, 5, 9, and 12 and as needed), telehealth peer service (daily during week 1, every other day during week 2, weekly during weeks 3-12, and as needed), and facilitated linkage to community resources and ongoing treatment. Adults aged 19 years or older with a diagnosis of opioid use disorder and a nonfatal opioid overdose within the previous 12 months were recruited before they were discharged from the University of Alabama at Birmingham Hospital. After enrollment, buprenorphine treatment was initiated or continued, and peer support specialists began engaging and coaching patients. Participants completed validated surveys at baseline and 1 and 3 months. Feasibility will be measured using enrollment and retention rates (benchmark of ≥70% at 3 months). Acceptability will be measured using patient satisfaction and credibility and expectancy scores. Mental health, craving, repeat overdose, and emergency department revisits and readmissions are secondary outcomes. Outcomes will be summarized descriptively. RESULTS The R61 study was funded by the National Institute on Drug Abuse from October 1, 2024, to August 30, 2026. All 30 anticipated participants were enrolled, and 24 completed the intervention. The last participant completed the intervention in April 2026. Data analysis is currently ongoing, and results from the current study are expected to be published in January 2027. Funding for the subsequent R33 phase was awarded in September 2026. CONCLUSIONS This study evaluated the feasibility and acceptability of a bundled telehealth-enabled intervention for patients at high risk of repeat overdose and death, a patient population with low treatment uptake and retention after hospital discharge. The findings will inform the upcoming R33 phase, a randomized controlled trial aiming to demonstrate effectiveness in an estimated sample of 160 patients. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/109601
- 17 August 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 292, 79-90
Physician-Targeted Interventions Reduce Surgical Expense and Improve Value-Driven Health Outcomes
- 17 August 2023
- Published by Elsevier in Journal of Surgical Research
- Vol. 292, 79-90
Physician-Targeted Interventions Reduce Surgical Expense and Improve Value-Driven Health Outcomes
- 26 April 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (3) , 979-986
Cost-benefit analysis of a patient engagement technology (PET) in cardiac, thoracic, and colorectal surgery
- 26 April 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (3) , 979-986
Cost-benefit analysis of a patient engagement technology (PET) in cardiac, thoracic, and colorectal surgery
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , e100-e101
Impact of Patient Engagement Technologies on Cost of the Surgical Encounter in Cardiac and Thoracic Surgery
Patient engagement technologies (PETs) guide patients through the perioperative period. PETs may improve surgical outcomes, however the cost-effectiveness of such technologies in high-cost surgeries such as cardiac and thoracic surgery is unknown.
- 1 November 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , e100-e101
Impact of Patient Engagement Technologies on Cost of the Surgical Encounter in Cardiac and Thoracic Surgery
Patient engagement technologies (PETs) guide patients through the perioperative period. PETs may improve surgical outcomes, however the cost-effectiveness of such technologies in high-cost surgeries such as cardiac and thoracic surgery is unknown.
- Open Access
- 1 October 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (4) , e105
Patient Engagement Technologies (PETs) Reduce the Costs of Index Surgical Encounters
- 1 October 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (4) , e105
Open AccessPatient Engagement Technologies (PETs) Reduce the Costs of Index Surgical Encounters
- 15 June 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (1) , 476-483
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
Hyperparathyroidism substantially impairs quality of life, and effective treatment depends on timely referral to surgeons. We hypothesized that there would
- 15 June 2020
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (1) , 476-483
Race and Gender Disparities in Access to Parathyroidectomy: A Need to Change Processes for Diagnosis and Referral to Surgeons
Hyperparathyroidism substantially impairs quality of life, and effective treatment depends on timely referral to surgeons. We hypothesized that there would